Concert Pharmaceuticals completes enrollment in second open label trial of CTP-543 in alopecia areata Read more
Novartis Cosentyx positive 16-week PREVENT results advance potential new indication for patients with axial spondyloarthritis Read more
FDA Accepts Merck’s BLA and Grants Priority Review for V920, the Company’s Investigational Vaccine for Ebola Zaire Virus Read more
Exclusive interview with Novartis industry leader, Maxime Gaillot, for the Wearable Injectors and Connected Devices conference 2019 in London Read more
Accenture Announces Collaboration with Bayer to Streamline Drug Development Processes through INTIENT Clinical Platform Read more
Alnylam Announces Initiation of APOLLO-B Phase 3 Study of Patisiran for the Treatment of Transthyretin Amyloidosis with Cardiomyopathy Read more
Amplyx Pharmaceuticals Licenses Phase 2 Drug Candidate for BK Viral Disease in Transplant Patients Read more